Cover Image

Recent Progress on Topical Drug Therapy for Corneal Neovascularization

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xin‐Can Huang, Guo‐Yang Xu, Pei‐Pei Yang, Lei Wang, Hao Wang, Ying Hu
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	ChemMedChem
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sulphur Analogues of Homoisoflavonoids as Potential Treatments for Neovascular Eye Diseases
by: Jacob D. Hiles, et al.
Published: (2026)

Progress of Mesoporous Silica Coated Gold Nanorods for Biological Imaging and Cancer Therapy
by: Jiaying Ma, et al.
Published: (2024)

Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
by: Sadık Hüseyin Cemali, et al.
Published: (2025)

Programmable Intelligent DNA Nanoreactors (iDNRs) for in vivo Tumor Diagnosis and Therapy
by: Ying Shen, et al.
Published: (2024)

Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
by: Jingjing Zhang, et al.
Published: (2024)

A Metal–Organic Nanoplatform Coassembled with Artesunate and Chlorin e6 for Synergistic Chemo/Photodynamic Cancer Therapy
by: Ling Yang, et al.
Published: (2026)

Targeting Tetraspanins at Cell Interfaces: Functional Modulation and Exosome‐Based Drug Delivery for Precise Disease Treatment
by: Kun Xu, et al.
Published: (2024)

Mitochondria‐Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes
by: Hao‐Ming Li, et al.
Published: (2024)

Recent Advances in Pretargeted Strategy for Cancer Theranostics
by: Yuyang Tian, et al.
Published: (2024)

The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy
by: Qiuying Nie, et al.
Published: (2024)

Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy
by: Lixiao Zhang, et al.
Published: (2025)

Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
by: Yaxin Lei, et al.
Published: (2025)

Antibacterial and Biofilm Removal Strategies Based on Micro/Nanomotors in the Biomedical Field
by: Wenlu Wu, et al.
Published: (2024)

Advances in Lipid Nanoparticle‐Based Disease Treatment
by: Yujie Zhou, et al.
Published: (2025)

NIR Enhanced pH‐Responsive Microneedles for Synergetic Therapy of Melanoma
by: Weiqiang Han, et al.
Published: (2024)

Pillar[n]arene‐Based Supramolecular Nanodrug Delivery Systems for Cancer Therapy
by: Shubin Wei, et al.
Published: (2025)

Higher Order Structure Differences Among Insulin Crystalline Drugs Revealed by 2D heteronuclear NMR
by: Songlin Wang, et al.
Published: (2024)

Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
by: Chao Tang, et al.
Published: (2026)

Adipocyte‐Targeted Nanotechnology and Cell‐Based Therapy for Obesity Treatment
by: Yue Wu, et al.
Published: (2025)

Adipocyte‐Targeted Nanotechnology and Cell‐Based Therapy for Obesity Treatment
by: Yue Wu, et al.
Published: (2024)

Naphtho[1,8‐ef]isoindole‐7,8,10(9H)‐trione as Novel Theranostic Agents for Photodynamic Therapy and Multi‐Subcellular Organelles Localization
by: Shaoying Tan, et al.
Published: (2024)

Front Cover: Polydopamine‐Based Light Responsive Nanoparticles with Magnetic Resonance Imaging Capabilities for Breast Cancer Photodynamic/Photothermal Therapy Combination Therapy (ChemMedChem 3/2026)
by: Yupeng Zhang, et al.
Published: (2026)

Cyclic Peptides Radiopharmaceuticals: A Concise Review of Ligand Identification, Radiolabeling, and Clinical Progress
by: Xiushuang Yuan, et al.
Published: (2026)

Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors
by: Jochem Nelen, et al.
Published: (2026)

Biosynthesis of Natural and Unnatural Perylenequinones for Drug Development
by: Zengping Su, et al.
Published: (2024)

Accelerating Drug Discovery through Knowledge Sharing
by: Rory C. McAtee
Published: (2026)

Exploring Synthesis Strategies and Interactions between MOFs and Drugs for Controlled Drug Loading and Release, Characterizing Interactions through Advanced Techniques
by: Lidia E. Chiñas‐Rojas, et al.
Published: (2024)

A Donor–Donor‐π‐Acceptor–Acceptor Type Photosensitizer for Efficient Photo‐Inactivation of Pathogens Within Biofilms and Host Cells
by: Yunli Xu, et al.
Published: (2026)

Significant Tumor Inhibition of Trimethyl‐152‐[L‐aspartyl]pheophorbide a in Tumor Photodynamic Therapy≠
by: Anita Benić, et al.
Published: (2025)

Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation
by: Junhyeong Yim, et al.
Published: (2024)

Tumor Microenvironment‐Responsive Multinucleated Nanocomplexes Loaded with Carbon Dots for Combined Photothermal/Chemodynamic Therapy of Breast Cancer
by: Zihan Zhu, et al.
Published: (2025)

Discovery of New CDDO‐Imidazole Derivatives as Potential Antitumor Agents
by: Yanqing Li, et al.
Published: (2026)

Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance
by: Linjia Su, et al.
Published: (2024)

Current Approaches and Strategies Applied in First‐in‐class Drug Discovery
by: Idrees Mohammed, et al.
Published: (2024)

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation
by: Jinmin Miao, et al.
Published: (2024)

Progress In the Chemistry and Pharmacology of Isoindolin‐1‐One Scaffolds
by: Kunal Madaan, et al.
Published: (2025)

Nano‐Engineering Strategies for Tumor‐Specific Therapy
by: Zijin Li, et al.
Published: (2024)

Recent Advances of Quinoline‐Based Small Molecules as Kinase Inhibitors (2020–2024)
by: Sara Sultan, et al.
Published: (2025)

Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)
by: K. Jagathesan, et al.
Published: (2024)

Recent Developments On Activatable Turn‐On Fluorogenic Donors of Hydrogen Sulfide (H2S)
by: Roopjyoti Misra, et al.
Published: (2024)